Performa Ltd (US), LLC - VISTAGEN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Performa Ltd (US), LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$9,163
-18.4%
4,900
-94.6%
0.01%
-16.7%
Q1 2023$11,223
+55.7%
90,000
+28.6%
0.01%
+50.0%
Q4 2022$7,210
-19.9%
70,000
+16.7%
0.00%
-33.3%
Q3 2022$9,000
-66.7%
60,000
+94.4%
0.01%
-70.0%
Q2 2022$27,000
-43.8%
30,859
-5.0%
0.02%
+25.0%
Q1 2022$48,000
+140.0%
32,500
+225.0%
0.02%
+33.3%
Q4 2021$20,000
+300.0%
10,000
+400.0%
0.01%
+300.0%
Q3 2021$5,0000.0%2,000
+17.6%
0.00%0.0%
Q2 2021$5,0001,7000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$32,135,00011.34%
VR Adviser, LLC 16,047,286$43,970,0005.65%
COMMODORE CAPITAL LP 5,123,509$14,038,0003.70%
Ghost Tree Capital, LLC 2,000,000$5,480,0001.60%
EPIQ PARTNERS, LLC 916,100$2,510,0001.16%
SILVERARC CAPITAL MANAGEMENT, LLC 707,733$1,939,0001.10%
SPHERA FUNDS MANAGEMENT LTD. 3,824,938$10,480,0000.88%
HighVista Strategies LLC 438,239$1,201,0000.80%
Nicholas Investment Partners, LP 2,786,354$7,635,0000.56%
NEA Management Company, LLC 16,302,596$44,669,0000.53%
View complete list of VISTAGEN THERAPEUTICS INC shareholders